| Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/05/2023 | ROSENWALD LINDSAY A MD | Director | Grant | COMMON STOCK, PAR VALUE $0.0001 | 7.2k | $0.00 | $0 | | 07/05/2023 |
| 07/05/2023 | WEISS MICHAEL S | Director | Grant | COMMON STOCK, PAR VALUE $0.0001 | 7.2k | $0.00 | $0 | See Footnote | 07/05/2023 |
| 07/05/2023 | Herskowitz Neil | Director | Grant | COMMON STOCK, PAR VALUE $0.0001 | 7.2k | $0.00 | $0 | | 07/05/2023 |
| 07/05/2023 | Chill Adam J. | Director | Grant | COMMON STOCK, PAR VALUE $0.0001 | 7.2k | $0.00 | $0 | | 07/05/2023 |
| 07/05/2023 | ZELEFSKY MICHAEL J | Director | Grant | COMMON STOCK, PAR VALUE $0.0001 | 7.2k | $0.00 | $0 | | 07/05/2023 |
| 04/24/2023 | Litchman Manuel MD | President and CEO | Grant | COMMON STOCK, PAR VALUE $0.0001 | 5k | $0.00 | $0 | | 04/24/2023 |
| 01/06/2023 | Fortress Biotech, Inc. | 10% Owner | Grant | COMMON STOCK, PAR VALUE $0.0001 | 2.8M | $0.00 | $0 | | 01/06/2023 |
| 09/13/2022 | ROSENWALD LINDSAY A MD | Director | Purchase | COMMON STOCK, PAR VALUE $0.0001 | 5k | $0.52 | $2.6k | | 03/18/2022 |
| 09/13/2022 | Litchman Manuel MD | President and CEO | Purchase | COMMON STOCK, PAR VALUE $0.0001 | 5k | $0.52 | $2.6k | | 03/18/2022 |
| 07/29/2022 | Chill Adam J. | Director | Grant | COMMON STOCK, PAR VALUE $0.0001 | 71.7k | $0.00 | $0 | | 07/29/2022 |
| 07/29/2022 | ROSENWALD LINDSAY A MD | Director | Grant | COMMON STOCK, PAR VALUE $0.0001 | 71.7k | $0.00 | $0 | | 03/18/2022 |
| 07/29/2022 | WEISS MICHAEL S | Director | Grant | COMMON STOCK, PAR VALUE $0.0001 | 71.7k | $0.00 | $0 | See Note 3 | 07/29/2022 |
| 07/29/2022 | Herskowitz Neil | Director | Grant | COMMON STOCK, PAR VALUE $0.0001 | 71.7k | $0.00 | $0 | | 07/29/2022 |
| 07/29/2022 | ZELEFSKY MICHAEL J | Director | Grant | COMMON STOCK, PAR VALUE $0.0001 | 71.7k | $0.00 | $0 | | 07/29/2022 |
| 06/21/2022 | Litchman Manuel MD | President and CEO | Grant | COMMON STOCK, PAR VALUE $0.0001 | 61k | $0.00 | $0 | | 03/18/2022 |
| 03/18/2022 | Litchman Manuel MD | President and CEO | Purchase | COMMON STOCK, PAR VALUE $0.0001 | 5k | $0.74 | $3.7k | | 03/18/2022 |
| 03/18/2022 | ROSENWALD LINDSAY A MD | Director | Purchase | COMMON STOCK, PAR VALUE $0.0001 | 4.1k | $0.74 | $3k | | 03/18/2022 |
| 12/14/2021 | Achenbach Brian | SVP, Fin. & Corp. Controller | Sale | COMMON STOCK | 4.4k | $1.83 | $8k | | 12/08/2021 |
| 12/08/2021 | Achenbach Brian | SVP, Fin. & Corp. Controller | Grant | COMMON STOCK | 22.5k | $0.00 | $0 | | 12/08/2021 |
| 10/27/2021 | Litchman Manuel MD | President and CEO | Purchase | COMMON STOCK | 65k | $2.24 | $145.6k | | 10/27/2021 |
| 10/12/2021 | Achenbach Brian | SVP, Fin. & Corp. Controller | Sale | COMMON STOCK | 4.4k | $2.28 | $10.1k | | 10/12/2021 |
| 08/31/2021 | Litchman Manuel MD | President and CEO | Grant | COMMON STOCK | 2.7k | $2.58 | $7.1k | | 08/31/2021 |
| 08/31/2021 | ROSENWALD LINDSAY A MD | Director | Grant | COMMON STOCK | 1.2k | $2.58 | $3k | | 08/31/2021 |
| 07/30/2021 | Litchman Manuel MD | President and CEO | Purchase | COMMON STOCK | 86.2k | $2.91 | $250.9k | | 07/30/2021 |
| 06/28/2021 | Chill Adam J. | Director | Grant | COMMON STOCK | 13.8k | $0.00 | $0 | | 06/28/2021 |
| 06/28/2021 | WEISS MICHAEL S | Director | Grant | COMMON STOCK | 13.8k | $0.00 | $0 | See Note 3 | 06/28/2021 |
| 06/28/2021 | ROSENWALD LINDSAY A MD | Director | Grant | COMMON STOCK | 13.8k | $0.00 | $0 | | 06/28/2021 |
| 06/28/2021 | Herskowitz Neil | Director | Grant | COMMON STOCK | 13.8k | $0.00 | $0 | | 06/28/2021 |
| 06/28/2021 | ZELEFSKY MICHAEL J | Director | Grant | COMMON STOCK | 13.8k | $0.00 | $0 | | 06/28/2021 |
| 06/17/2021 | Litchman Manuel MD | President and CEO | Grant | COMMON STOCK | 61k | $0.00 | $0 | | 06/17/2021 |
| 04/09/2021 | Achenbach Brian | SVP, Fin. & Corp. Controller | Sale | COMMON STOCK | 2.4k | $3.36 | $8.1k | | 12/06/2019 |
| 03/05/2021 | Litchman Manuel MD | President and CEO | Purchase | COMMON STOCK | 165.6k | $3.12 | $516.6k | | 02/26/2021 |
| 02/26/2021 | Litchman Manuel MD | President and CEO | Grant | COMMON STOCK | 5k | $2.83 | $14.2k | | 02/26/2021 |
| 12/15/2020 | Litchman Manuel MD | President and CEO | Purchase | COMMON STOCK | 100k | $2.91 | $291k | | 08/31/2020 |
| 12/15/2020 | Achenbach Brian | SVP, Fin. & Corp. Controller | Grant | Common Stock | 22.5k | $0.00 | $0 | | 12/15/2020 |
|